Israel Englander Gritstone Bio, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Gritstone Bio, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 1,140,508 shares of GRTS stock, worth $34,215. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,140,508

Previous 1,108,176 2.92%

Holding current value

$34,215

Previous $687,000 3.78%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.45 - $0.71 $14,549 - $22,955	32,332 Added 2.92%	1,140,508 $661,000
Q2 2024 Aug 14, 2024	BUY	$0.62 - $2.35 $687,069 - $2.6 Million	1,108,176 New	1,108,176 $687,000
Q4 2023 Feb 14, 2024	SELL	$1.28 - $2.85 $1.63 Million - $3.62 Million	-1,271,227 Reduced 98.13%	24,210 $49,000
Q2 2023 Aug 14, 2023	BUY	$1.66 - $3.03 $969,803 - $1.77 Million	584,219 Added 82.14%	1,295,437 $2.53 Million
Q1 2023 May 15, 2023	BUY	$2.13 - $3.74 $1.35 Million - $2.37 Million	634,887 Added 831.76%	711,218 $1.98 Million
Q4 2022 Feb 14, 2023	SELL	$2.17 - $3.92 $471,167 - $851,141	-217,128 Reduced 73.99%	76,331 $263,000
Q3 2022 Nov 14, 2022	SELL	$2.46 - $4.75 $1.96 Million - $3.79 Million	-798,008 Reduced 73.11%	293,459 $754,000
Q2 2022 Aug 15, 2022	BUY	$1.77 - $4.34 $865,393 - $2.12 Million	488,923 Added 81.14%	1,091,467 $2.64 Million
Q1 2022 May 16, 2022	BUY	$4.03 - $12.19 $2.43 Million - $7.35 Million	602,544 New	602,544 $2.48 Million
Q3 2021 Nov 15, 2021	SELL	$6.41 - $13.54 $1.76 Million - $3.73 Million	-275,123 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$8.13 - $10.2 $3.08 Million - $3.86 Million	-378,797 Reduced 57.93%	275,123 $2.51 Million
Q1 2021 May 17, 2021	BUY	$4.07 - $27.11 $2.19 Million - $14.6 Million	539,128 Added 469.66%	653,920 $6.17 Million
Q4 2020 Feb 16, 2021	BUY	$2.57 - $4.22 $129,175 - $212,109	50,263 Added 77.89%	114,792 $452,000
Q3 2020 Nov 16, 2020	SELL	$2.63 - $8.09 $309,522 - $952,104	-117,689 Reduced 64.59%	64,529 $171,000
Q2 2020 Aug 14, 2020	BUY	$5.69 - $8.17 $1.04 Million - $1.49 Million	182,218 New	182,218 $1.21 Million
Q4 2019 Feb 14, 2020	SELL	$7.07 - $11.61 $83,666 - $137,392	-11,834 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$8.45 - $12.28 $99,997 - $145,321	11,834 New	11,834 $102,000
Q4 2018 Feb 14, 2019	SELL	$11.61 - $31.1 $1 Million - $2.69 Million	-86,522 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$14.24 - $14.24 $1.23 Million - $1.23 Million	86,522 New	86,522 $1.23 Million

Others Institutions Holding GRTS

# of Institutions

Shares Held

35.4M

Call Options Held

395K

Put Options Held

132K

View Full List

About Gritstone bio, Inc.

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

More about GRTS

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account